Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nutrition-related derangements and managements in patients with cystic fibrosis: robust challenges for preventing the development of co-morbidities.

Clinical biochemistry - 1 May 2011

Levy Emile

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Canada
Share to Comorbidity
Share to Diabetes Mellitus
Share to Intestinal Absorption

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipid Metabolism

Share to Nutrition Assessment

Share to Nutritional Status

Share to Pancreas

Source

Identifiers

PMID: 22036340
DOI: 10.1016/j.clinbiochem.2011.03.126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nutrition-related derangements and managements in patients with cystic fibrosis: robust challenges for preventing the development of co-morbidities.PMID 22036340Read ↗

Evolving Nutritional Needs in Cystic FibrosisSemantic proximity Read ↗

Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications.Semantic proximity Read ↗

Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era.Semantic proximity Read ↗

Gastrointestinal pathophysiology and nutrition in cystic fibrosis.Semantic proximity Read ↗

[Nutrition, cystic fibrosis and the digestive tract].Semantic proximity Read ↗

Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and BeyondSemantic proximity Read ↗

Nutritional and metabolic management for cystic fibrosis in a post-cystic fibrosis transmembrane conductance modulator era.Semantic proximity Read ↗

The Impact of Highly Effective CFTR Modulators on Growth and Nutrition Status.Semantic proximity Read ↗

Beyond the Lungs-Emerging Challenges in Adult Cystic Fibrosis Care.Semantic proximity Read ↗

Update on Cystic Fibrosis in Pediatric Patients.Semantic proximity Read ↗

Addressing the Nutritional Phenotype Through Personalized Nutrition for Chronic Disease Prevention and ManagementSemantic proximity Read ↗

Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.